Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome - Related Studies

Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome

This study is ongoing, but not recruiting participants.

Study NCT00003984. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Myelodysplastic Syndromes

2	Additional conditions recognized in this trial
		Preleukemia
		Syndrome

3	More general conditions related to this trial
		Bone Marrow Diseases
		Disease
		Hematologic Diseases
		Neoplasms
		Pathologic Processes
		Precancerous Conditions

4	Interventions listed in this trial
		lintuzumab

5	Additional drug interventions recognized in this trial
		Antibodies, Monoclonal

6	More general drug interventions related to this trial
		Immunologic Factors
		Pharmacologic Actions
		Physiological Effects of Drugs

7	Sponsors listed in this trial
		European Organization for Research and Treatment of Cancer